We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 6th:
Momenta Pharmaceuticals, Inc. : This biotechnology company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.3% over the last 60 days.
Purple Innovation, Inc. (PRPL - Free Report) : This designer and manufacturer of mattresses, pillows, and cushions has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Zscaler, Inc. (ZS - Free Report) : This cloud security company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40% over the last 60 days.
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Image: Shutterstock
Top Ranked Momentum Stocks to Buy for July 6th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 6th:
Momenta Pharmaceuticals, Inc. : This biotechnology company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.3% over the last 60 days.
Momenta Pharmaceuticals, Inc. Price and Consensus
Momenta Pharmaceuticals, Inc. price-consensus-chart | Momenta Pharmaceuticals, Inc. Quote
Momenta's shares gained 0.2% over the last one month compared to S&P 500’s fall of -2%. The company possesses a Momentum Score of A.
Momenta Pharmaceuticals, Inc. Price
Momenta Pharmaceuticals, Inc. price | Momenta Pharmaceuticals, Inc. Quote
Purple Innovation, Inc. (PRPL - Free Report) : This designer and manufacturer of mattresses, pillows, and cushions has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
PURPLE INNOVATION, INC. Price and Consensus
PURPLE INNOVATION, INC. price-consensus-chart | PURPLE INNOVATION, INC. Quote
Purple Innovation’s shares gained 16.5% over the last one month. The company possesses a Momentum Score of B.
PURPLE INNOVATION, INC. Price
PURPLE INNOVATION, INC. price | PURPLE INNOVATION, INC. Quote
Zscaler, Inc. (ZS - Free Report) : This cloud security company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40% over the last 60 days.
Zscaler, Inc. Price and Consensus
Zscaler, Inc. price-consensus-chart | Zscaler, Inc. Quote
Zscaler's shares gained 11% over the last one month. The company possesses a Momentum Score of B.
Zscaler, Inc. Price
Zscaler, Inc. price | Zscaler, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>